基于术前MRI影像组学预测浸润性乳腺癌D2-40淋巴管侵犯
本研究回顾性纳入203例病理确诊的浸润性乳腺癌患者,随机分为训练集141例和测试集62例,基于术前DCE-MRI提取影像组学特征并结合临床危险因素构建列线图模型。列线图模型在训练集和测试集的AUC分别为0.873(95%CI:0.807-0.923)和0.902(95%CI:0.800-0.963),决策曲线显示其净收益优于单纯影像组学模型和临床模型。
要点
- 术前DCE-MRI影像组学列线图可无创预测浸润性乳腺癌D2-40定义的淋巴管侵犯状态。
- 淋巴结大小是预测淋巴管侵犯的独立临床危险因素,被纳入列线图。
- 列线图在训练集与测试集均表现出良好的校准与区分度,测试集AUC达0.902。
核心结论
- 基于术前DCE-MRI的列线图模型对浸润性乳腺癌D2-40定义的淋巴管侵犯具有满意的无创预测效能。
研究设计与样本
- 回顾性研究,纳入203例病理确诊的浸润性乳腺癌患者,随机分为训练集141例和测试集62例。
- 采用单因素和多因素logistic回归筛选独立危险因素并构建临床模型。
- 采用LASSO logistic回归从早期和延迟增强DCE-MRI图像中筛选特征并建立影像组学标签,再结合影像组学评分与危险因素构建列线图模型。
- 以ROC曲线、校准曲线和决策曲线评价各模型效能,参考标准为D2-40判定的淋巴管侵犯。
关键影像表现/征象
- 共筛选出14个影像组学特征用于构建影像组学模型。
- 淋巴结大小被识别为临床模型的独立危险因素。
诊断标准与关键数值
- 列线图模型训练集AUC为0.873(95%CI:0.807-0.923),测试集AUC为0.902(95%CI:0.800-0.963)。
- 列线图模型在训练集和测试集中均表现出最佳的校准与区分性能。
- 决策曲线显示列线图模型较影像组学标签和临床模型带来更多净收益。
临床应用与阅片要点
- 术前可基于DCE-MRI影像组学评分联合淋巴结大小评估淋巴管侵犯风险,辅助个体化治疗规划。
- 影像组学特征来自早期和延迟增强DCE-MRI图像,勾画与特征提取需规范以保证可重复性。
局限性
- 为单中心回顾性研究,样本量203例,外部验证不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Preoperative prediction of LVI status can facilitate personalized therapeutic planning. This study aims to investigate the efficacy of preoperative MRI-based radiomics for predicting lymphatic vessel invasion (LVI) determined by D2-40 in patients with invasive breast cancer.
MATERIALS AND METHODS: A total of 203 patients with pathologically confirmed invasive breast cancer, who underwent preoperative breast MRI, were retrospectively enrolled and randomly assigned to the following cohorts: training cohort (n=141) and test cohort (n=62). Then, univariate and multivariate logistic regression were performed to select independent risk factors and build a clinical model. Afterwards, least absolute shrinkage and selection operator (LASSO) logistic regression was performed to select predictive features extracted from the early and delay enhancement dynamic contrast-enhanced (DCE)-MRI images, and a radiomics signature was established. Subsequently, a nomogram model was constructed by incorporating the radiomics score and risk factors. Receiver operating characteristic curves were performed to determine the performance of various models. The efficacy of the various models was evaluated using calibration and decision curves.
RESULTS: Fourteen radiomics features were selected to construct the radiomics model. The size of the lymph node was identified as an independent risk factor of the clinical model. The nomogram model demonstrated the best calibration and discrimination performance in both the training and test cohorts, with an area under the curve of 0.873 (95% confidence interval [CI]: 0.807-0.923) and 0.902 (95% CI: 0.800-0.963), respectively. The decision curve illustrated that the nomogram model added more net benefits, when compared to the radiomics signature and clinical model.
CONCLUSION: The nomogram model based on preoperative DCE-MRI images exhibits satisfactory efficacy for the noninvasive prediction of LVI determined by D2-40 in invasive breast cancer.
引用
- Wu, Lin, Song, et al. Evaluation of Lymphatic Vessel Invasion Determined by D2-40 Using Preoperative MRI-Based Radiomics for Invasive Breast Cancer. Acad Radiol. 2022. PMID: 36586760. doi:10.1016/j.acra.2022.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。